Alex Fair, MS

CEO / Managing Director

MedStartr Venture Funds, LLC

New York, New York United States


Hospital and Health Care, Greater New York City Area

Investor

About Me

While working on his Ph.D. in Pathology at the Medical College of Wisconsin, Alex took a break to found his first health tech startup. That first company was bought by a company that had just gone public and he has never looked back, starting new companies and running them ever since. He still wants to cure cancer and fix healthcare, but now he does so by enabling hundreds of new companies to get to market faster and more reliably. He has also served as adviser or mentor to over 120 startups.

  • Project : GlucoSight - Blood Sugar at the Speed of Sight

    Comment : Love this idea, looking forward to the device, even just for personal, non diagnostic use.

    Posted on : 9th August, 2016
  • Project : Expediting a Promising Stem Cell Treatment for Quadriplegia

    Comment : Thanks for the update - great news! Keep us posted.

    Posted on : 3rd November, 2016
  • Project : AI and chatbot powered CRM for providers.

    Comment : Good to see a Blueprint Health company on MedStartr - Good luck Chinmay!

    Posted on : 25th October, 2017
  • Project : UroCycler, Automatic Bladder Management System

    Comment : Hi Robert, yes, that link was not working, fixed now.

    Posted on : 31st July, 2019
  • No data found. Lets change that!
    Discover Projects

    No data found. Lets change that!
    Discover Projects

    No data found. Lets change that!
    Discover Projects

    No data found. Lets change that!
    Discover Projects

    Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.